当前位置: 首页 > 期刊 > 《中国当代医药》 > 2010年第16期
编号:12029374
白细胞介素-6与肾小球疾病的关系(2)
http://www.100md.com 2010年6月5日 《中国当代医药》 2010年第16期
     [6]Harada K, Akai Y, Kurumatani N,et al.Prognostic value of urinary interleukin 6 in patients with IgA nephropathy:An 8-Year follow-up study[J].Nephron,2002,92(4):824-826.

    [7]刘小平,胡顺金,方琦.大鼠 IgA 肾病模型的建立及血清中IL-6、FN、NO 的检测[J].中国比较医学杂志,2008,18(1):5-8.

    [8]Watts RA, Scott DG.Epidemiology of the vasculities[J].Current Opinion in Rheumatol,2003,15(1):11-16.

    [9]余振,彭晓东.过敏性紫癜肾炎患儿血清IL-6 IL-8 MMP-9变化及意义[J].河北医学,2008,14(5):573-575.

    [10]Hirohata S, Miyamoto T.Elevated levels of interleukin-6 in cerebrospinal fluid from patientswith systemic lupus erythematosus and central nervous system involement[J].Arthritis Rheum,1990,33(5):644-649.

    [11]Cash H,Relle M,Menke J,et al.Interleukin 6(IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice:The IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus[J].The Journal of Rheumatology,2010,37(1):60-70.

    [12]Panichi V,Migliori M,De Pietro S,et a1.Creactive pro-tein as a marker of chronic infl am mation in uremia patients[J].Blood Purif,2000,18(3):183-190.

    [13]Garibotto G, Sofia A, Procopio V,et al.Perpheral tissue release of interleukin-6 in patients with chronic kidney diseasea:effects of end-stage renal disease and micrionflammatory state[J].International Society of Nephrology,2006,70(2):384-390.

    (收稿日期:2010-04-30), 百拇医药(段翠蓉 李志辉)
上一页1 2